Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Analysis of Revenues

Microsoft Excel

Revenues as Reported

Abbott Laboratories, income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Established Pharmaceutical Products
Nutritional Products
Diagnostic Products
Medical Devices
Reportable segments
Other
Net sales to external customers

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Item Description The company
Net sales to external customers Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Abbott Laboratories net sales to external customers increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.